24-Apr-2026
Teladoc Health to Announce First Quarter 2026 Financial Results
Globe Newswire (Wed, 15-Apr 4:05 PM ET)
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Mon, 13-Apr 12:20 PM ET)
Globe Newswire (Thu, 2-Apr 10:18 AM ET)
Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
Globe Newswire (Mon, 30-Mar 4:30 PM ET)
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
Globe Newswire (Wed, 4-Mar 4:05 PM ET)
Teladoc Health to Participate in Upcoming Investor Conference
Globe Newswire (Tue, 3-Mar 4:05 PM ET)
Teladoc Health Reports Narrower Net Loss in 2025 as Integrated Care Drives Adjusted EBITDA Growth
Market Chameleon (Thu, 26-Feb 6:28 AM ET)
Teladoc Health Reports Fourth Quarter and Full Year 2025 Results
Globe Newswire (Wed, 25-Feb 4:05 PM ET)
Globe Newswire (Wed, 18-Feb 4:30 PM ET)
Teladoc Health to Announce Fourth Quarter 2025 Financial Results
Globe Newswire (Thu, 5-Feb 4:30 PM ET)
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
Teladoc Health trades on the NYSE stock market under the symbol TDOC.
As of April 24, 2026, TDOC stock price climbed to $5.75 with 3,253,137 million shares trading.
TDOC has a beta of 2.12, meaning it tends to be more sensitive to market movements. TDOC has a correlation of 0.29 to the broad based SPY ETF.
TDOC has a market cap of $1.02 billion. This is considered a Small Cap stock.
Last quarter Teladoc Health reported $642 million in Revenue and -$.14 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.07.
In the last 3 years, TDOC traded as high as $30.41 and as low as $4.40.
The top ETF exchange traded funds that TDOC belongs to (by Net Assets): VTI, IWM, VB, AVUV, VXF.
TDOC has underperformed the market in the last year with a return of -20.8%, while the SPY ETF gained +31.9%. In the last 3 month period, TDOC fell short of the market, returning -9.2%, while SPY returned +3.8%. However, in the most recent 2 weeks TDOC has outperformed the stock market by returning +12.7%, while SPY returned +5.1%.
TDOC support price is $5.47 and resistance is $5.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TDOC shares will trade within this expected range on the day.
